Warren Hamel and Maggie Grace published "The Fourth Circuit Limits FCA Liability in cGMP Cases" in Bloomberg BNA's Pharmaceutical Law & Industry Report on April 18, 2014.
Click to view "The Fourth Circuit Limits FCA Liability in cGMP Cases."
April 18, 2014 | Bloomberg BNA's Pharmaceutical Law & Industry Report
The Fourth Circuit Limits FCA Liability in cGMP Cases
1 min
Related Services
Practices
Related Insights
The State of Biosimilars in 2023
The State of Biosimilars in 2023
March 17, 2023
1min
DOJ Announces Corporate Criminal Self-Disclosure Policy for All U.S. Attorneys' Offices
DOJ Announces Corporate Criminal Self-Disclosure Policy for All U.S. Attorneys' Offices
February 28, 2023
3min
Recent DOJ Memo on Corporate Criminal Enforcement Highlights Critical Considerations for Employers
Recent DOJ Memo on Corporate Criminal Enforcement Highlights Critical Considerations for Employers
November 29, 2022
4min
Recent News
Venable Client Nelstone Ventures Leads Allermi Seed Round with $3.4 Million Investment
Venable Client Nelstone Ventures Leads Allermi Seed Round with $3.4 Million Investment
March 20, 2023
1min
Baltimore Business Journal Once Again Recognizes Venable Among Its Middle Market Leaders in Greater Baltimore
Baltimore Business Journal Once Again Recognizes Venable Among Its Middle Market Leaders in Greater Baltimore
March 17, 2023
1min
Venable Advises Online Security Provider Aura on Partnership with Robert Downey Jr.
Venable Advises Online Security Provider Aura on Partnership with Robert Downey Jr.
March 17, 2023
1min